361 related articles for article (PubMed ID: 30848198)
21. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
22. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
23. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
25. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma.
Ziogas IA; Sioutas G; Mylonas KS; Tsoulfas G
Microrna; 2020; 9(1):25-40. PubMed ID: 31218966
[TBL] [Abstract][Full Text] [Related]
26. Novel biomarkers in hepatocellular carcinoma.
De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
[TBL] [Abstract][Full Text] [Related]
27. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
Xu J; Li J; Zheng TH; Bai L; Liu ZJ
Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
[TBL] [Abstract][Full Text] [Related]
30. Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms.
Sayed GI; Solyman M; El Gedawy G; Moemen YS; Aboul-Ella H; Hassanien AE
Sci Rep; 2024 Feb; 14(1):4989. PubMed ID: 38424116
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
32. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
35. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
Yang L; Wei C; Li Y; He X; He M
Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
[No Abstract] [Full Text] [Related]
36. Diagnostic role of microRNA-125b for hepatocellular carcinoma.
Li F; Bao QW; Jiang LY; Huang QL; Zhang X; Chen JX
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):395-397. PubMed ID: 31266727
[No Abstract] [Full Text] [Related]
37. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
38. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
39. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
